Yesterday's news that Invitrogen is buying Applied Biosystems for $6.7 billion stirred tremendous interest from the community. Our sister website GenomeWeb Daily News reports that "the deal would be the largest in the life sciences tools market since Thermo Electron bought Fisher Scientific for $10.6 billion in 2006." Invitrogen CEO Greg Lucier will head up the whole company, and current Applera CEO Tony White will be a consultant for five years once the deal is approved.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.